Insiders who purchased Biomea Fusion, Inc. (NASDAQ:BMEA) shares in the past 12 months are unlikely to be deeply impacted by the stock's 15% decline over the past week. Reason being, despite the recent loss, insiders original purchase value of US$87k is now worth US$113k.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
See our latest analysis for Biomea Fusion
The Last 12 Months Of Insider Transactions At Biomea Fusion
The CFO & Principal Accounting Officer Franco Valle made the biggest insider purchase in the last 12 months. That single transaction was for US$87k worth of shares at a price of US$8.68 each. We do like to see buying, but this purchase was made at well below the current price of US$11.32. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.
The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
NasdaqGS:BMEA Insider Trading Volume September 21st 2022
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership Of Biomea Fusion
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. From our data, it seems that Biomea Fusion insiders own 1.9% of the company, worth about US$6.3m. However, it's possible that insiders might have an indirect interest through a more complex structure. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
What Might The Insider Transactions At Biomea Fusion Tell Us?
The fact that there have been no Biomea Fusion insider transactions recently certainly doesn't bother us. But insiders have shown more of an appetite for the stock, over the last year. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Biomea Fusion stock. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Our analysis shows 4 warning signs for Biomea Fusion (2 can't be ignored!) and we strongly recommend you look at them before investing.
Of course Biomea Fusion may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
購買的內部人士Biomea Fusion公司納斯達克(Sequoia Capital:BMEA)過去12個月的股價不太可能受到過去一週下跌15%的嚴重影響。原因是,儘管最近出現了虧損,但內部人士最初購買的8.7萬美元現在價值11.3萬美元。
雖然我們永遠不會建議投資者應該完全根據公司董事的所作所為做出決定,但我們認為完全忽視內幕交易是愚蠢的。
查看我們對Biomea Fusion的最新分析
Biomea Fusion最近12個月的內幕交易
首席財務官兼首席會計官佛朗哥·瓦萊在過去12個月中進行了最大規模的內部收購。這一筆交易是以每股8.68美元的價格收購了價值8.7萬美元的股票。我們確實希望看到買入,但這次買入的價格遠遠低於目前11.32美元的價格。雖然這確實表明內部人士認為該股在較低的價格下被低估了,但這筆交易並沒有告訴我們他們對當前價格的看法。
下面的圖表顯示了過去一年的內幕交易(按公司和個人)。通過點擊下面的圖表,你可以看到每一筆內幕交易的準確細節!
NasdaqGS:BMEA內幕交易量2022年9月21日
內部人士總是在買入大量股票。因此,如果這適合你的風格,你可以逐一檢查每一種庫存,或者你可以看看這個免費公司名單。(提示:內部人士一直在買入這些股票)。
Biomea Fusion的內部人所有權
另一種測試公司領導人與其他股東之間一致性的方法是看他們擁有多少股份。我們通常希望看到相當高水平的內部人士持股。從我們的數據來看,Biomea Fusion內部人士似乎持有該公司1.9%的股份,價值約630萬美元。然而,內部人士可能會通過更復雜的結構擁有間接利益。總體而言,這種所有權水平並不令人印象深刻,但肯定比什麼都沒有好!
Biomea Fusion的內幕交易可能會告訴我們什麼?
最近沒有Biomea Fusion的內幕交易,這一事實當然不會讓我們感到困擾。但在過去一年裏,內部人士對該股表現出了更大的興趣。雖然我們不擔心內幕交易,但如果他們持有更多的Biomea Fusion股票,我們會更放心。雖然我們喜歡知道內部人士的所有權和交易情況,但在做出任何投資決定之前,我們也要確保考慮到一隻股票面臨的風險。我們的分析顯示生物羣融合的4個警告信號(2不可忽視!)我們強烈建議你在投資之前先看看它們。
當然了Biomea Fusion可能不是最值得購買的股票。所以你可能想看看這個免費彙集了高質量的公司。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。